Xitandi 40MG gcap 120S
Ended Awarded
- Contract number
- SPE2DX25FKVRJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $21,557
Award facts
- Contract value 100% obligated
- $21,556.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $21,556.75 for Xtandi 40mg capsules (120-count units) on June 25, 2025, with an ultimate completion date of June 26, 2025. The award carries no set-aside designation and is funded by the Defense Logistics Agency's Medical Supply Chain division. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026, which authorizes the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities.
Xtandi, an oral oncology medication used in prostate cancer treatment, represents one of many specialty pharmaceutical products DMS Pharmaceutical Group supplies to Department of Defense healthcare sites nationwide. The vendor has established itself as a critical supplier in the federal pharmaceutical supply chain through its portfolio of branded and generic prescription drugs, biologics, and medical consumables. This delivery order exemplifies the operational structure of the DLA's SPE2DB program, under which the government issues individual delivery orders for specific pharmaceutical items needed to support military medical operations and healthcare delivery systems across federal facilities worldwide.
Quick answers
Who was awarded contract SPE2DX25FKVRJ?
SPE2DX25FKVRJ was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on June 25, 2025.
How much is contract SPE2DX25FKVRJ worth?
The government has obligated $21,557 on SPE2DX25FKVRJ.
Is contract SPE2DX25FKVRJ an order under another contract?
Yes. SPE2DX25FKVRJ is a delivery order under SPE2DX15D9628, an indefinite delivery contract.
Was contract SPE2DX25FKVRJ competed?
The extent of competition for SPE2DX25FKVRJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award